Related by context. All words. (Click for frequent words.) 82 MKC# MT 81 AFREZZA ™ 80 AFRESA ® 80 AFREZZA TM 79 MKC# MKC# PP 74 AAG geldanamycin analog 74 Mg Usa 74 Meets Primary Endpoint 74 Completes Patient Enrollment 74 topical gel formulation 74 TBC# 73 Initiates Phase II 73 orally administered inhibitor 73 liposomal formulation 73 pralatrexate injection folate analogue 73 Zorbtive TM 73 products MKC# PP 73 developing Bicifadine serotonin 73 AFREZZA ® 73 Empatic TM 73 oncolytic virus therapies 73 oritavancin semi 73 delta opioid receptor 73 Vitrasert R 73 approved incretin mimetic 73 XL# anticancer compounds 73 Inhalation Aerosol 73 LymphoStat B belimumab 73 sapacitabine CYC# 73 vinorelbine tartrate 72 oral picoplatin 72 Qnexa TM 72 ALN HPN 72 VEGFR2 inhibitor 72 includes investigational compounds 72 DP VPA 72 Xcytrin R 72 delivers fluocinolone acetonide FA 72 Empatic ™ 72 hypertension osteoarthritis 72 metaglidasen 72 Quinamed R 72 IMiDs ® 72 albiglutide 72 myocardial infarction ventricular fibrillation 72 Achieves Primary Endpoint 72 R Saizen R 72 IMiDs R 72 6 sulfatase 72 targeted radiotherapeutic 72 Files IND 72 orally inhaled 72 Saxagliptin 72 oral ghrelin agonist 72 TELINTRA R 72 includes TOLAMBA TM 72 phenylalanine ammonia lyase 72 Completes Enrollment 72 Phase 2b Clinical Trial 72 Glucagon Like Peptide 71 induced macular edema 71 brand ciclesonide HFA 71 Begins Dosing 71 Receives Orphan Drug Designation 71 Gamunex C 71 5 HT3 antagonist 71 Pivotal Phase 71 Mg Uk 71 Pramlintide 71 FDA APPROVES 71 novel VDA molecule 71 Commences Phase 71 HepeX B TM 71 sodium glucose cotransporter 71 Pivotal Phase III 71 synthetic lipoglycopeptide antibiotic 71 Crofelemer budesonide foam 71 phase III isavuconazole 71 Phase 2b Trial 71 Initiates Enrollment 71 Panzem R 71 NU# direct 71 RELOVAIR ™ 71 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 71 oral nucleoside analogue 71 vapreotide acetate 71 IMPDH inhibitor 71 mecarbil 71 Medidur ™ FA 71 including eniluracil ADH 71 orally ingestible insulin 71 Submits NDA 71 Pruvel TM 71 Phase IIb Trial 71 cromolyn sodium 71 Custirsen 71 PRN FDA Approves 71 TNF Tumor Necrosis Factor 71 clinical trials Archexin 71 QNEXA ® 71 delta gamma agonist 71 non porcine pancreatic 71 arsenic trioxide injection 71 intranasal formulation 70 norepinephrine reuptake inhibitor 70 LUNESTA ® 70 Initiates Clinical 70 alfimeprase direct 70 Vicriviroc 70 formerly LymphoStat B 70 rosiglitazone maleate 70 Tezampanel 70 octreotide acetate 70 CYT# potent vascular disrupting 70 AERx R 70 2 methoxyestradiol 70 Hydrochlorothiazide Tablets 70 Iluvien ® 70 Testosterone MDTS ® 70 Inhalation Powder 70 leading oral taxane 70 personalized cellular immunotherapy 70 Veronate R 70 humanized therapeutic 70 Archexin 70 davalintide 70 Peginterferon alfa 2b 70 herpetic keratitis 70 oral dihydropyrimidine dehydrogenase DPD 70 oral prodrug 70 Syncria albiglutide 70 Investigational Oral 70 recombinant PSMA vaccine 70 TRANSDUR ® 70 sulfonylurea glimepiride 70 oral proteasome inhibitor 70 Albugon 70 Ovitrelle R Serostim 70 Receives Approvable Letter 70 humanized interleukin 6 70 Pegloticase 70 methylnaltrexone bromide 70 Transdermal Patch 70 SinuNase TM 70 docetaxel Taxotere R 70 Launches Generic Version 70 reslizumab 70 beta 1a 70 Atripla combines 70 GVAX ® 70 inhalation powder 70 cortisol synthesis 70 incretin mimetic 70 VISICOL R 70 CYP#A# CYP#D# 70 pulmonology portfolio 70 Daclizumab 69 Elagolix 69 DUROS 69 delivery polymer matrix 69 Personalized Immunotherapy 69 XP# XP# 69 Initiates Phase III 69 retinal vein occlusion induced 69 acyclovir Lauriad R 69 sublingual tablet formulation 69 Initiate Phase 69 pharmacogenomic translational research 69 neuropathic pain metabolic diseases 69 Monopril 69 MAGE A3 ASCI 69 Dapagliflozin 69 iobenguane 69 interferon gamma 1b 69 BCG refractory carcinoma 69 overactive bladder AA# 69 Phase 2a Clinical Trial 69 Announces Tentative Approval 69 selective A2A adenosine receptor 69 R metformin Concor 69 inflammatory autoimmune diseases 69 novel orally inhaled 69 catheter occlusion 69 ADP receptor antagonist 69 Aciphex R 69 R sorafenib tablets 69 Retisert ® 69 Luramist TM 69 Aflibercept 69 non nucleoside inhibitor 69 MOVIPREP R 69 Namenda ® 69 Safinamide 69 granisetron formulated 69 Phase Ib IIa 69 pharmacologically active isomer 69 nasal calcitonin product 69 AKT inhibitor 69 2A receptor agonist 69 R MSCRAMM 69 5 lipoxygenase inhibitor 69 lead molecular radiotherapeutic 69 6R BH4 69 buccal spray 69 non peptidic protease 69 Initiates Phase 69 HIV treatments Reyataz 69 Qutenza TM 69 Zolpimist ™ 69 Abbokinase 69 human rDNA origin 69 serine protease inhibitor CU# 69 Telik logo TELINTRA 69 LymphoStat B TM 69 selective modulator 69 gastrin analogue TT 69 Dementia Related Psychosis 69 HuMax TAC 69 Ceflatonin R 69 induced mucositis 69 HCV RNA polymerase 69 markets Testim ® 69 Submits Biologics License Application 69 First Patient Dosed 69 inhaled formulation 69 Investigational Treatment 69 Drug Candidate 69 myasthenia gravis Huntington 69 Hemispherx flagship products 69 Aridol TM 69 Zoraxel TM 69 Mylan Receives Approval 69 hypoxia activated prodrug 69 generation purine nucleoside 69 metformin HCl 69 HuMax 69 topically applied SEPA 69 oral dual endothelin 69 toenail onychomycosis 69 tenofovir disoproxil fumarate Viread 69 Procardia XL 69 pan histone deacetylase 69 Initiates Clinical Trial 69 kidney urologic 69 sulfonylurea metformin 69 next generation URAT1 69 Single Dose 69 GALNS N acetylgalactosamine 69 virus HCV protease inhibitor 69 PEGylated Fab fragment 68 Liprotamase 68 Novel Oral 68 either acutely decompensated 68 OAB overactive bladder 68 gets USFDA nod 68 evaluating picoplatin 68 PGL# 68 triggers apoptosis programmed 68 SGLT2 inhibitor 68 SAR# [002] 68 somatostatin analog 68 diarrhea predominant irritable 68 nucleoside analog 68 REPRONEX R menotropins 68 Genasense ® oblimersen 68 ® pramlintide acetate 68 reduce serum phosphate 68 accumulate preferentially 68 compound INCB# 68 metformin hydrochloride 68 R bisoprolol Euthyrox 68 peripherally acting 68 inflammatory PDE 68 COPEGUS R 68 SinuNase ™ 68 sapropterin dihydrochloride Phase 68 Mipomersen 68 ® lenalidomide 68 Presents Preclinical 68 somatostatin analogue 68 selective receptor agonist 68 AFRESA 68 Roche Boniva 68 Ridaforolimus 68 Budesonide foam crofelemer 68 dependent kinase inhibitor 68 pioglitazone HCl 68 A1PI 68 Phase #b/#a clinical 68 Zenpep 68 memantine HCl 68 Patients Treated With 68 acetonide FA 68 modified glutathione analog 68 5 fluorouracil leucovorin 68 Serostim ® 68 PNP inhibitor 68 recurrent metastatic ovarian cancer 68 HCl PEPCID ® famotidine 68 Amgen Neulasta R 68 Hsp# Inhibitor 68 Submits Response 68 sapropterin dihydrochloride 68 SPRYCEL ® 68 candidate XP# 68 Teva Provides Update 68 SUPPRELIN R LA 68 ATPace TM 68 rhIGF-I/rhIGFBP-3 68 Sudhir Agrawal D.Phil 68 Ondansetron Injection USP 68 developing Zerenex ferric 68 R pramlintide acetate 68 hyperphenylalaninemia HPA due 68 ketoconazole USP Gel 68 Febuxostat 68 NeuroSTAT ® 68 BRILINTA 68 INSPIRE Trial Phase III 68 proprietary BiTE ® 68 Testosterone MDTS R 68 Commence Phase 68 docetaxel Taxotere ® 68 investigational compounds 68 novel topoisomerase 68 Fluticasone 68 oral isotype selective HDAC 68 AVAPRO 68 Glatiramer Acetate 68 markets HP Acthar 68 hyaluronidase enzyme 68 Initiate Clinical Trial 68 Lispro 68 Benazepril 68 PROCTOCORT R 68 mGluR5 NAM 68 ATRA IV 68 Successfully Completes Phase 68 tumor activated prodrug 68 budesonide foam 68 Phase IIa Clinical Trial 68 Trial Evaluating 68 Phase III Clinical Trial 68 highly purified pasteurized 68 Letairis ambrisentan 68 Trandolapril 68 COLAZAL R 68 DEB# 68 sodium glucose transporter 68 inhalation aerosol 68 FOLOTYN ® 68 CEL SCI Phase III 68 PROVIGIL ® 68 lintuzumab SGN 68 PLX STROKE targeting 68 Seroquel quetiapine fumarate 68 Randomized Phase 68 P#X# antagonist 68 generation URAT1 inhibitor 68 ALGRX 68 Hormone Refractory Prostate Cancer 68 candidates Azedra TM 68 cosmetic cosmeceutical products 68 MUSE ® 68 product Fentanyl TAIFUN 68 Phase III Pivotal 68 protein tyrosine phosphatase 1B 68 Dual Opioid 68 Camptosar ® 68 THR beta agonist 68 seliciclib CYC# 68 Syncria R 68 Nipent R 68 TRACON Pharmaceuticals 68 5 HT4 68 Gel repository corticotropin injection 68 Pafuramidine 68 Gastrointestinal Liner 68 MSCRAMM ® 68 omega interferon 68 drug pipeline TAFA# 68 interferon beta 1a infertility 68 PresbyLens ® 68 COLAZAL ® 68 R brand eszopiclone 68 Xanafide 68 oral transmucosal 68 Valopicitabine 68 UCB Keppra 68 dyslipidemia hypertension diabetes 68 Ostabolin C TM 68 TRIOLEX HE# APOPTONE HE# 68 clonidine hydrochloride 68 HCl Injection 68 Patient Enrollment 68 systemic juvenile idiopathic 67 dasatinib Sprycel ® 67 muscarinic receptor agonist 67 Pimavanserin 67 Mycophenolate Mofetil 67 successfully commercialize Iluvien 67 PDE4 inhibitor 67 Warner Chilcott Actonel 67 rheumatoid arthritis psoriatic arthritis 67 corticosteroid dexamethasone 67 PEG PAL PEGylated recombinant 67 CCR9 antagonist 67 Tesetaxel 67 CTAP# Capsules 67 QNEXA 67 GTC recombinant human 67 dopamine partial agonist 67 Soliris eculizumab 67 TKB# 67 Phase 2a Trial 67 Prodarsan R 67 Recombinant Human 67 evaluating Actimmune 67 Inhalation Solution 67 essential thrombocythemia ET 67 BENLYSTA TM 67 Unigene nasal calcitonin 67 lexidronam injection 67 candidate TNFerade biologic 67 novel emulsion formulation 67 aldehyde dehydrogenase ALDH2 deficiency 67 folate analogue metabolic 67 azilsartan medoxomil 67 Phase 1b Clinical Trial 67 Investigational Compound 67 Oral NKTR 67 Piperacillin 67 investigational pharmacologically unique 67 potent CYP#A# inhibitors 67 Interferon beta 1a 67 urocortin 2 67 BUPHENYL 67 ACTIQ ® 67 Long acting beta2 67 Pfizer Camptosar 67 AN# topical anti 67 Intermezzo ® zolpidem tartrate 67 refractory chronic lymphocytic 67 PERLANE 67 IMiDs ® compound 67 PEGylated anti 67 dimebon latrepirdine 67 rusalatide acetate 67 Vidaza R 67 doxepin HCl 67 Orphan Status 67 Granted Orphan Drug 67 Pazopanib 67 PrevOnco ™ 67 ALN VSP Phase 67 XIAFLEX ® 67 MTP inhibitor 67 Files Investigational 67 Besivance 67 RhuDex ® 67 Carbidopa Levodopa 67 cytomegalovirus immune globulin 67 Maribavir 67 Technosphere ® 67 Cetrorelix 67 Albuferon TM 67 DURIN TM 67 Fast Track Status 67 ragweed allergy immunotherapeutic 67 Demonstrates Significant 67 NEBIDO R 67 Peginterferon 67 product platforms AZX# 67 Epothilone D 67 #HT# 67 thetreatment 67 treat chronic sinusitis 67 SPL# Gel vaginal microbicide 67 liver resection surgeries 67 novel synthetic PEGylated 67 orally bioavailable mimics 67 Sapacitabine 67 Prochymal TM 67 Prodrug 67 CYP#A# isoenzyme 67 Diamyd r 67 HCV NS5B polymerase 67 Humanized Anti 67 Orally administered 67 Initiates Phase 2b 67 PEGylated docetaxel 67 Iluvien TM 67 Azmacort R 67 cardiac myosin activator omecamtiv 67 Oral Calcitonin 67 nilotinib Tasigna ® 67 Troxatyl 67 motexafin gadolinium Injection 67 selective phosphodiesterase 67 abobotulinumtoxinA 67 M# rationally 67 vascular occlusive diseases 67 monoclonal antibody IgG1 Mab 67 FUSILEV ® 67 Vildagliptin 67 Anturol TM 67 DG# compounds targeting 67 Boniva ibandronate 67 topically administered 67 overactive bladder VANTAS R 67 Luveris R Ovidrel R 67 Rigel R# 67 VIVITROL ® 67 Demonstrates Positive 67 EndoBarrier ™ 67 Adjunctive Therapy 67 Aceon 67 Metformin HCl 67 Levoleucovorin 67 Acetavance TM intravenous acetaminophen 67 rheumatoid arthritis inflammatory bowel 67 prescribed proton pump 67 Clinical Trial Evaluating 67 novel DACH platinum 67 signal detection CTSD 67 Vidaza ® 67 hoFH 67 TRIOLEX ™ 67 BENLYSTA ® 67 HYVISC ® treatment 67 fluocinolone acetonide 67 Retisert R 67 Eltrombopag 67 label Lipofen R 67 Gentamicin Surgical Implant 67 modafinil Tablets C 67 candesartan cilexetil 67 Warfarin Coumadin 67 mertansine 67 candidates Azedra 67 individualized cellular immunotherapy 67 Losartan Potassium 67 apomorphine hydrochloride 67 Naive Patients 67 vitreoretinal disorders 67 Tegretol carbamazepine 67 ABLYNX 67 investigational oral inhibitor 67 EnteroMedics proprietary neuroblocking technology 67 Contrave# 67 CRTH2 67 rasagiline tablets 67 Bayer HealthCare Onyx Pharmaceuticals 67 Icatibant 67 candidate SMaRT Replacement 67 xanthine oxidase inhibitor 67 Neulasta R 67 Granulocyte Colony Stimulating Factor 67 Omacetaxine 67 evaluating bafetinib 67 highly selective endothelin 67 bone marrow reticulin deposition 67 pentadentate logo R 67 NS5B polymerase 67 SURFAXIN r 67 vinca alkaloid 67 oral Janus kinase 67 Divalproex Sodium 67 CYT# QbG# 67 ENABLE Phase 2 67 Degarelix 67 R roscovitine CDK cyclin 67 Deferiprone 67 Syncria 67 Ganciclovir 67 Mesafem 67 Tipranavir 67 Tramiprosate ALZHEMED TM 67 Second Pivotal Phase 67 Proellex TM 67 therapeutically inactive prodrug 67 orally disintegrating 67 PHX# 67 INS# [001] 67 Saizen ® 67 cutaneous T 67 miconazole Lauriad ® 67 Gemzar gemcitabine 67 GW# [003] 67 plus prednisone prednisolone 67 sublingual tablets 66 iloprost synthetic compound 66 markets COLAZAL 66 zileuton injection 66 Initiates Clinical Trials 66 Avanafil 66 molecular imaging radiopharmaceutical 66 PEGINTRON TM 66 MEK Inhibitor 66 PSN# [002] 66 hormone LHRH antagonist 66 IMA# 66 include Phenoptin TM 66 NICE Recommends 66 metformin sulfonylureas 66 Tibotec Therapeutics division 66 Silodosin 66 sorafenib tablets 66 thrombin component 66 Bazedoxifene 66 Pivotal Trial 66 YONDELIS 66 Vernakalant 66 BUPHENYL R 66 Kosan proprietary 66 erlotinib Tarceva R 66 HuCAL PLATINUM ® CysDisplay 66 ZOLINZA 66 treat opioid induced 66 dihydroergotamine DHE 66 occlusion PAO 66 Oral Insulin 66 Frozen Shoulder syndrome Adhesive 66 Zalypsis 66 development peramivir neuraminidase 66 Cardium Therapeutics TM 66 Ticagrelor 66 ALTROPANE R 66 CDK cyclin dependent 66 albiglutide currently 66 Lubiprostone 66 RANK Ligand inhibitor 66 ADCC enhanced 66 selective immunoproteasome inhibitor 66 TRANSDUR ™ 66 sodium thiosulfate STS 66 ABILIFY ® 66 Am J Obstet 66 insulin glulisine 66 long acting muscarinic 66 ALVESCO ® 66 Glucotrol XL 66 Solulin 66 Kuvan sapropterin dihydrochloride 66 ALN PCS 66 candidate AQ4N 66 Tofacitinib 66 aripiprazole Abilify 66 include Alferon N 66 Study Evaluating 66 myelodysplastic myeloproliferative diseases 66 1mg 2mg 66 Alexza Staccato 66 syndrome overactive bladder 66 antibody MAb 66 Acetate Rectal Suppositories 66 recombinant Factor VIIa 66 peptidic compound 66 CNS Disorders 66 TELINTRA 66 Serostim R 66 Ecallantide 66 Parnate 66 Oxytrol R 66 Presents Positive 66 mGluR5 negative 66 Solzira TM 66 GLP1 agonist 66 Methylnaltrexone 66 PI3K/Akt pathway inhibitor 66 proprietary intravenous formulation 66 agonistic human 66 Primary Hypercholesterolemia 66 Pravachol pravastatin 66 Cannabinor 66 FDA Okays 66 bucindolol hydrochloride 66 Suppository Hydrocortisone Acetate Rectal 66 Temsirolimus 66 PEGylated irinotecan 66 SYCREST 66 R#/MEM # 66 Aloprim TM allopurinol sodium 66 prematurity Stargardt disease 66 selective serotonin 2C receptor 66 compound KOS 66 Melphalan 66 candidate Zemiva 66 Receives Positive Opinion 66 #mg #mg #mg #mg [002] 66 includes AstraZeneca Accolate 66 oral renin inhibitor 66 Evoltra ® 66 fentanyl citrate C 66 Presents Preclinical Data 66 FDA Approvals 66 Pemetrexed 66 vaginal candidiasis 66 platform HDL Mimetic 66 using VIAdel TM 66 BENICAR HCT 66 oxybutynin ATD TM 66 Alfacell proprietary ribonuclease 66 AAG KOS 66 TRISENOX R arsenic trioxide 66 ergot derivatives 66 uricase 66 benzoic acid hyoscyamine sulfate 66 fibrosis IPF 66 Muraglitazar 66 oxypurinol 66 lamotrigine Lamictal 66 inhibitor PPI 66 CIMZIA TM 66 OMNARIS Nasal Spray 66 GLP1 INT TM 66 rheumatoid arthritis thrombocytopenia 66 olmesartan medoxomil hydrochlorothiazide 66 Novartis Trileptal 66 telomerase therapeutic 66 DepoCyt ® Abelcet ® 66 Adjuvant Treatment 66 Phase IIb Clinical Trial 66 ChronVac C R 66 developing ACAPODENE 66 insulin aspart 66 gefitinib Iressa 66 Complicated Skin 66 Loceryl ® 66 calcitonin salmon nasal spray 66 Aztreonam lysine 66 Indacaterol 66 non splenectomized 66 Aptivus ® 66 Amgen Neulasta ® 66 NanoTab 66 Bosutinib 66 oral transmucosal fentanyl citrate 66 salmeterol fluticasone 66 Submits Supplemental 66 Prolongs Survival 66 hepatitis C lupus 66 IL# PE#QQR 66 maleate 66 receptor inhibiting monoclonal 66 dextromethorphan quinidine 66 Testim R 66 Alocrest 66 candidate deforolimus 66 D aspartate NMDA receptor 66 By JAMAAL ABDUL 66 volociximab 66 BENICAR 66 Tasimelteon 66 Glufosfamide 66 EOquin TM phase 66 midstage clinical 66 PEGylated interferon 66 psoriasis rheumatoid arthritis 66 Focalin XR R 66 topical antifungal product 66 PSMA ADC 66 Bicalutamide 66 Initiated Phase 66 dopamine D2 66 Solzira ™ 66 secretory phospholipase A2 66 FDA Accepts 66 Multiple Ascending Dose 66 opioid induced bowel dysfunction 66 E1 INT TM 66 systemic anaplastic large 66 IMiDs 66 CTAP# 66 Factor VIIa 66 Pruvel 66 Adagen ® 66 octreotide implant 66 EQUATE OB 66 TNFerade TM 66 IgG1 monoclonal antibody 66 ® tiagabine hydrochloride 66 cytidine nucleoside analog 66 IV meropenem 66 oral antidiabetic medication 66 TRO# 66 Auxilium transmucosal film 66 relapsed leukemia 66 Diovan Exforge Tekturna Zelnorm 66 sterile lidocaine patch 66 immunotherapeutic agent 66 Wafer polifeprosan 66 TMC# [002] 66 Dabigatran etexilate 66 Combination REOLYSIN R 66 Ropinirole 66 Trastuzumab DM1 66 Frova ® 66 oral beclomethasone dipropionate 66 thiazolidinedione TZD 66 VIAtab TM 66 ABL inhibitor 66 Talabostat 66 small molecule Hedgehog 66 orally inhaled migraine 66 Aurora Kinase 66 proliferator activated receptor 66 chronic eosinophilic leukemia 66 ALVESCO R 66 Soriatane R 66 ELND-#/AZD-# 66 R famotidine 66 quetiapine fumarate 66 Clolar ® 66 Lenocta 66 Peptide YY 66 Bristol Myers Squibb Pravachol 66 NB S# strontium malonate 66 Atelvia 66 pan HDAC inhibitor 66 J Am Coll 66 solid tumors ZYBRESTAT 66 Kamada AAT 66 JZP 66 polysaccharide polymer 66 JAK2 Inhibitor 66 initiated Phase Ib 66 Genzyme Synvisc 66 FOLFOX6 chemotherapy regimen 66 agent bevasiranib 66 DPP4 inhibitor 66 BUPHENYL R sodium phenylbutyrate 66 5 FU capecitabine 66 ZANAFLEX CAPSULES ® tizanidine 66 Linagliptin 66 Ambrisentan 66 LANTUS R 66 small molecule glucokinase 66 rALLy 66 somatropin Kuvan R 66 dihydrochloride 66 relapsed MM 66 Randomized Double blind 66 Adenoscan R 66 Gonal f R 66 non cirrhotic portal 66 2 inhibitor CYT# 66 diabetes irritable bowel 66 NovoLog ® insulin aspart 66 Zemiva TM 66 ELADUR ™ 66 HyperAcute 65 Pharma Merck Serono 65 rxRNA 65 Tenormin 65 Endologix Powerlink System 65 armodafinil Tablets C 65 Aztreonam Lysine 65 Darapladib 65 oral Hsp# inhibitor 65 Novartis Reclast 65 CRM# Protein 65 R memantine HCl 65 dihydroergotamine mesylate DHE 65 oral rivaroxaban 65 Advicor R 65 serotonin norepinephrine reuptake inhibitor 65 pan BCR ABL 65 Aztreonam 65 XYOTAX TM 65 Perforomist ™ Inhalation Solution 65 Belimumab 65 nalbuphine ER 65 Generic Version 65 SUTENT ® 65 tizanidine hydrochloride short 65 lucinactant 65 CYP#A# substrate 65 Xyfid TM 65 investigational monoclonal antibody 65 Receives Milestone Payment 65 QVA# 65 BEMA Granisetron 65 Trobalt 65 Infusion Reactions Severe 65 adenosine injection 65 Navelbine ® 65 Selzentry Celsentri 65 PDX pralatrexate 65 small molecule thrombopoietin 65 insulin detemir rDNA origin 65 mequinol 65 combines propoxyphene 65 LAB CGRP 65 tramiprosate Alzhemed TM 65 Anturol ® 65 mGluR2 positive 65 Intravitreal 65 Epanova 65 anti amnesic 65 Aganocide 65 Perforomist TM formoterol fumarate 65 Taclonex R 65 Treatment Naïve 65 #mg/#mg 65 Confirmatory Phase 65 Anidulafungin 65 balsalazide disodium 65 candidate REP# 65 Rebif ® 65 demonstrated antitumor activity 65 VYVANSE TM lisdexamfetamine 65 OMNARIS HFA 65 combines bupropion 65 Cleviprex TM clevidipine 65 CCR5 mAb 65 inhibit oxidative stress 65 Pruvel ™ 65 faropenem medoxomil 65 opioid naive 65 palonosetron hydrochloride Injection Dacogen 65 Formoterol 65 highly selective inhibitor 65 Receives Orphan Drug 65 tiapamil 65 IONSYS TM 65 polyneuropathy HIV DSP 65 % pramoxine HCl 65 Combivir Kivexa 65 orally dosed 65 acetylgalactosamine 6 65 Survivin antagonist 65 Fosphenytoin 65 damage cirrhosis liver 65 corticotropin injection 65 Pivotal Study 65 alfa 2a 65 RapidMist 65 Shows Promise Against 65 include GALNS N 65 Intravenous CP 65 Cetrorelix pamoate 65 orally disintegrating formulation 65 Proc Am Soc 65 antidepressants fluoxetine 65 Romiplostim 65 Antithrombin 65 evaluating tivozanib 65 Aryplase 65 PORxin TM platforms 65 PSN# [001] 65 ALS #-# 65 DURECT proprietary 65 use transdermal sumatriptan 65 brand eszopiclone XOPENEX 65 Major Depressive Disorder MDD 65 lead Aganocide compound 65 topical anti infective 65 Sanofi Pasteur Fluzone 65 investigational antiplatelet agent 65 novel antimitotic agent 65 IAP inhibitor 65 non constipating irritable 65 Diabetic Neuropathy 65 Ciclesonide 65 Prilosec omeprazole 65 granulated mesalamine 65 intravesical infusion therapy 65 ATS Simulus R 65 Aliskiren 65 Aradigm Logo 65 Tumour Vascular Disrupting Agent 65 Technosphere R 65 transdermal fentanyl 65 dihydroergotamine 65 R DepoCyt 65 Hycamtin ® 65 Soriatane 65 bowel syndrome Non 65 dopamine receptor agonist 65 HGS ETR1 mapatumumab 65 taxane derivative 65 PROSTASCINT R 65 systemic lupus erythematosus rheumatoid 65 aplastic anemia AA 65 paclitaxel Taxol ® 65 Zanaflex Capsules TM 65 Epratuzumab 65 Civacir 65 Eraxis 65 Tyrosine Kinase Inhibitor 65 anti PlGF 65 ethinyl estradiol tablets 65 GRNOPC1 contains 65 topical non steroidal 65 erlotinib Tarceva ® 65 MERREM 65 TNFerade ™ 65 candidate ATHX